Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agile Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
From Agile Therapeutics, Inc.
Via GlobeNewswire
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Agile Therapeutics: Q4 Earnings Insights
Via Benzinga
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
From Agile Therapeutics, Inc.
Via GlobeNewswire
Agile Therapeutics's Earnings: A Preview
Via Benzinga
Agile Therapeutics's Earnings: A Preview
Via Benzinga
Why Agile Therapeutics (AGRX) Stock Is Down 60%
Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its trading on the Nasdaq effective Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Agile Therapeutics Announces Delisting from Nasdaq
From Agile Therapeutics, Inc.
Via GlobeNewswire
Earnings Scheduled For March 22, 2024
Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million. 
Via Benzinga
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
Live Conference Call and Webcast at 8:30 a.m. ET 
From Agile Therapeutics, Inc.
Via GlobeNewswire
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
Live Conference Call and Webcast at 8:30 a.m. ET 
From Agile Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Elimination of Remaining Debt to Perceptive Advisors Leaves the Company’s Balance Sheet Debt Free 
From Agile Therapeutics, Inc.
Via GlobeNewswire
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Etsy, Inc. 
Via Benzinga
What's Going On With Women Health Focused Agile Therapeutics Stock Today?
Agile Therapeutics stock rises on premarket trading, exercising warrants for $4.8M gross proceeds with reduced exercise price of $1.25 per share. 
Via Benzinga
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
From Agile Therapeutics, Inc.
Via GlobeNewswire
Why Is Bel Fuse (BELFB) Stock Down 17% Today?
Bel Fuse stock is falling on Thursday as investors in BELFB shares react to the company's lackluster Q4 2023 earnings report. 
Via InvestorPlace
Why Is Draganfly (DPRO) Stock Down 48% Today?
Draganfly stock is down on Thursday after the company announced details for a $3.6 million public offering of DPRO shares. 
Via InvestorPlace
Why Is BuzzFeed (BZFD) Stock Up 101% Today?
BuzzFeed stock is rising higher on Thursday as investors in BZFD react to it selling Complex for $108.6 million in cash. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
Agile Therapeutics stock is rising higher on Thursday with heavy trading of AGRX shares despite a lack of news from the company. 
Via InvestorPlace
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning! 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
From Agile Therapeutics, Inc.
Via GlobeNewswire
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
From Agile Therapeutics, Inc.
Via GlobeNewswire
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS